IIM
MXCT icon

INTECH Investment Management’s MaxCyte MXCT Stock Holding History

INTECH Investment Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19K Sell
27,027
-17,334
-39% -$16.2K ﹤0.01% 2068
2025
Q4 		$68.8K Sell
44,361
-3,541
-7% -$5.66K ﹤0.01% 2229
2025
Q3 		$75.7K Sell
47,902
-13,481
-22% -$23.4K ﹤0.01% 2319
2025
Q2 		$134K Buy
61,383
+965
+2% +$2.34K ﹤0.01% 2217
2025
Q1 		$165K Buy
60,418
+28,206
+88% +$111K ﹤0.01% 2163
2024
Q4 		$134K Buy
32,212
+19,098
+146% +$72.2K ﹤0.01% 2144
2024
Q3 		$51K Buy
+13,114
New +$55.3K ﹤0.01% 1981

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

INTECH Investment Management's MXCT Position: Q1 2026 in Review

INTECH Investment Management reduced its MaxCyte (MXCT) stake by 39% in Q1 2026, selling an estimated $16.2K and leaving 27,027 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

INTECH Investment Management first reported a position in MXCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $165K in Q1 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • INTECH Investment Management held 27,027 shares of MaxCyte worth $19K as of Q1 2026.
  • INTECH Investment Management sold 17,334 MaxCyte shares in Q1 2026, an estimated $16.2K.
  • MaxCyte made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #2068 holding.
  • INTECH Investment Management first reported a position in MaxCyte in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's MaxCyte position peaked at $165K in Q1 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.